POT1 mutations are frequent and associated with Ki-67 index in canine diffuse large B-cell lymphoma
- PMID: 36016811
- PMCID: PMC9396242
- DOI: 10.3389/fvets.2022.968807
POT1 mutations are frequent and associated with Ki-67 index in canine diffuse large B-cell lymphoma
Abstract
Diffuse large B-cell lymphoma (DLBCL) represents one of the most frequent and deadliest neoplasia in dogs worldwide and is characterized by a remarkable degree of clinical heterogeneity, with poor chances to anticipate the outcome. Even if in the last years some recurrently mutated genes have been identified, the genetic origin of canine DLBCL (cDLBCL) is not yet completely understood. The aim of the present study was to assess the prevalence of POT1 mutations in cDLBCL and to elucidate the role of such gene in the pathogenesis of this tumor. Mutations in POT1 were retrieved in 34% of cases, in line with previous reports, but no significant associations with any clinico-pathological variable were identified. Likewise, POT1 mutations are not predictive of worse prognosis. Interestingly, Ki-67 index was significantly higher in dogs harboring POT1 mutations compared to wild-type ones. These results suggest that POT1 mutations may exert their pathogenic role in cDLBCL by promoting cellular proliferation.
Keywords: Ki-67; POT1; diffuse large B-cell lymphoma; dog; mutation.
Copyright © 2022 Fanelli, Marconato, Licenziato, Minoli, Rouquet and Aresu.
Conflict of interest statement
Author NR was employed by Hastim. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures



Similar articles
-
The prevalence and characterisation of TRAF3 and POT1 mutations in canine B-cell lymphoma.Vet J. 2020 Dec;266:105575. doi: 10.1016/j.tvjl.2020.105575. Epub 2020 Nov 21. Vet J. 2020. PMID: 33323169
-
Expanding the Spectrum of Canine Diffuse Large B-Cell Lymphoma Genetic Aberrations Through Whole Genome Sequencing Analysis.Vet Comp Oncol. 2025 May 4. doi: 10.1111/vco.13059. Online ahead of print. Vet Comp Oncol. 2025. PMID: 40320296
-
The genomic landscape of canine diffuse large B-cell lymphoma identifies distinct subtypes with clinical and therapeutic implications.Lab Anim (NY). 2022 Jul;51(7):191-202. doi: 10.1038/s41684-022-00998-x. Epub 2022 Jun 20. Lab Anim (NY). 2022. PMID: 35726023
-
Diffuse large B-cell lymphoma.Pathology. 2018 Jan;50(1):74-87. doi: 10.1016/j.pathol.2017.09.006. Epub 2017 Nov 20. Pathology. 2018. PMID: 29167021 Review.
-
Extranodal Diffuse Large B Cell Lymphoma: Molecular Features, Prognosis, and Risk of Central Nervous System Recurrence.Curr Treat Options Oncol. 2018 Jun 21;19(8):38. doi: 10.1007/s11864-018-0555-8. Curr Treat Options Oncol. 2018. PMID: 29931605 Free PMC article. Review.
Cited by
-
Predictive value of TP53 RNAscope®in situ hybridization and p53 immunohistochemistry for TP53 mutational status in canine diffuse large B-cell lymphoma.Vet Q. 2024 Dec;44(1):1-9. doi: 10.1080/01652176.2024.2403453. Epub 2024 Sep 16. Vet Q. 2024. PMID: 39282821 Free PMC article.
-
PD-L1, PD-1, and CTLA-4 mRNA In Situ Expression by Canine Oral Melanoma Cells and Immune Cells of the Tumour Microenvironment.Vet Comp Oncol. 2025 Jun;23(2):141-151. doi: 10.1111/vco.13039. Epub 2025 Jan 9. Vet Comp Oncol. 2025. PMID: 39789732 Free PMC article.
-
Proliferation in Minimal Invasive Samples of Canine Lymphomas: Ki67 Index in Previously Stained Cytology and Paired Cell Blocks.Vet Sci. 2025 Jun 8;12(6):561. doi: 10.3390/vetsci12060561. Vet Sci. 2025. PMID: 40559798 Free PMC article.
-
Identification of novel genetic mutations for the treatment prognostication of canine lymphoma.NPJ Precis Oncol. 2025 Jun 12;9(1):174. doi: 10.1038/s41698-025-00988-5. NPJ Precis Oncol. 2025. PMID: 40506464 Free PMC article.
References
-
- Richards KL, Motsinger-Reif AA, Chen HW, Fedoriw Y, Fan C, Nielsen DM, et al. . Gene profiling of canine B-cell lymphoma reveals germinal center and postgerminal center subtypes with different survival times, modeling human DLBCL. Cancer Res. (2013) 73:5029–39. 10.1158/0008-5472.CAN-12-3546 - DOI - PMC - PubMed
-
- Aresu L, Ferraresso S, Marconato L, Cascione L, Napoli S, Gaudio E, et al. . New molecular and therapeutic insights into canine diffuse large B-cell lymphoma elucidates the role of the dog as a model for human disease. Haematologica. (2019) 104:e256–e9. 10.3324/haematol.2018.207027 - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources